Why Citius Pharmaceuticals (CTXR) Stock Is Down 15%

BenzingaJan 8 22:38

Citius Pharmaceuticals Shares Are Trading Lower After the Company Announced a $3 Million Registered Direct Offering Priced At-the-market Under Nasdaq Rules.

BenzingaJan 8 21:25

Express News | Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

BreakingsJan 8 21:00

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

PR NewswireJan 8 21:00

Sector Update: Health Care

MT NewswiresJan 8 04:34

Citius Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow JonesJan 7 21:18 · Ratings